Search results
FDA approves CereVasc’s eShunt system study for hydrocephalus
Medical Device Network via Yahoo Finance· 2 hours agoThe US Food and Drug Administration (FDA) has granted investigational device exemption (IDE)...
Transphobia Makes Chest Binding More Dangerous
Time via Yahoo News· 44 minutes agoSome of these teens resort to using ACE bandages, which are more readily available but far more dangerous because they are designed to compress...
Study: 'New car smell' could be toxic carcinogens released by flame retardants
UPI· 5 hours agoFlame retardant chemicals added to seat foam and other car components pollute the cabin air inside...
Study: Street drugs are getting more potent and more mysterious
Rhode Island Current via Yahoo News· 2 hours agoWhen it comes to street drugs in Rhode Island, they don’t make them like they used to, a recent ...
Missouri has fifth highest gun death rate, new study says. Where does Kansas come in?
Kansas City Star via Yahoo News· 47 minutes agoMissouri has the fifth highest gun death rate in the nation, according to a study published Tuesday...
‘Ozempic babies’: What the science says on whether GLP-1s lead to surprise pregnancies, and their...
CNN via Yahoo News· 1 hour agoNumerous women have shared stories of “Ozempic babies” on social media. But the joy some experience...
Pfizer reports fatality in Phase II DMD gene therapy study
Clinical Trials Arena via Yahoo Finance· 1 hour agoPfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene...
Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of...
WKRN Nashville· 1 hour agoLin Shen from Beijing Cancer Hospital at the upcoming ASCO Annual Meeting in Chicago. Dr. Shen will present the results from the Phase I/II clinical study of MHB088C, a well-differentiated ...
California police unions slam study naming state best for officers: 'Not what we're hearing'
Fox News via Yahoo News· 4 hours agoSeveral California police unions have come out against a recent WalletHub study that concluded the...
Promino Nutritional Sciences and Dr. Patrick Gunning to Begin Preclinical Studies Focused on...
FOX40 Sacramento· 2 hours agoPromino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or...